henhaobio
Sign in

The American Journal of Human GeneticsGenetic & Genomic MedicinePeer-reviewed journal article

Genetic risk estimates for offspring of patients with Stargardt disease

Stéphanie S. CornelisiD, Esmee H. RunhartiD, Miriam BauwensiD, Zelia CorradiiD, Elfride De BaereiD, Susanne RoosingiD, Lonneke Haer‐WigmaniD, Claire‐Marie DhaenensiD, Anneke T. Vulto‐van SilfhoutiD, Frans P.M. CremersiD

PDFDOIPreprint

Abstract

BACKGROUNDGenetic counseling in autosomal recessive Stargardt disease (STGD1) is complicated because of unknown frequencies of pathogenic ABCA4 alleles across populations, variable and unknown severity of ABCA4 alleles, and incomplete penetrance. METHODSIn this cross-sectional study, published ABCA4 variants were categorized by severity based on previous functional and clinical studies and current statistical comparisons of their frequencies in patients versus the general population, their observed versus expected homozygous occurrence in patients, and their occurrence in combination with established mild alleles in patients. The sum allele frequencies of these severity categories were used to estimate inheritance risks for offspring of STGD1 patients and carriers of pathogenic ABCA4 variants. RESULTSThe risk for offspring of a STGD1 patient with the severe|severe genotype or a severe|mild with complete penetrance genotype to develop STGD1 at some moment in life was estimated at 2.8-3.1% (1 in 35-32 individuals) and 1.6-1.8% (1 in 62-57 individuals), respectively. The risk to develop STGD1 in childhood was estimated to be 2 to 4-fold lower: 0.7-0.8% (1 in 148-124) and 0.3-0.4% (1 in 295-248), respectively. For offspring of an unaffected ABCA4 variant carrier from a STGD1 family who carries one severe or one mild ABCA4 variant with complete penetrance, the risk to develop STGD1 throughout life is 1.4-1.6% (1 in 71-64) and 0.19-0.21% (1 in 516-487), respectively. CONCLUSIONWe propose a genotype-based personalized counseling approach to appreciate the large differences in inheritance risk between individuals. We advocate considering the lower risk of early-onset STGD1 compared with the total STGD1 risk.

Citations
55
FWCI
4.73
Field percentile
top 3%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISCornelis '23Khan '20Nomura '20Don '26Blauwendraa '23Fridman '21
71% semantic matchGenetic & Genomic Medicine
Stéphanie S. Cornelis, Miriam Bauwens, Lonneke Haer‐Wigman+6 more·medRxiv·Apr 24, 2023· 5 citations